-
Moderna and Merck report that a new mRNA anti-cancer vaccine under investigation used in combination with standard therapy to treat stage IV melanoma reduces risk of relapse compared to standard therapy alone.
Medical Mythbusting Commentary for December 14, 2022 Source:Experimental mRNA cancer vaccine with immunotherapy reduces risk of melanoma returning, preliminary study finds Reference: Awaiting data release and publication
-
Hopefully, RSV vaccine data submissions will fulfill Health Canada’s approval criteria so that our older folks and infants will be better protected in the new year.
Medical Mythbusting Commentary for November 25, 2022 Source:Seniors at high risk for RSV, experts warn, as Health Canada reviews 60-plus vaccine
-
Many hypotheses under investigation to understand what leads to dementia. Creating a preventative vaccine will be difficult and take time because we need to test these hypotheses to determine why and how this occurs.
Medical Mythbusting Commentary for November 23, 2022 Source:Dementia vaccines: What are they, and when could they become available?
-
Pneumococcal Vaccine Uptake Remains Low Among Vulnerable Canadians
Medical Mythbusting Commentary for November 16, 2022 Source:Pneumococcal Vaccine Uptake Remains Low Among Vulnerable Canadians Reference:Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA)
-
Researchers seek to understand why vaccine responses vary from person to person
Medical Mythbusting Commentary for November 9, 2022 Source:Researchers seek to understand why vaccine responses vary from person to person Reference:Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination
-
Pfizer RSV vaccine data submitted to FDA for evaluation. Large international study found vaccinating during pregnancy was nearly 82% effective at preventing severe RSV cases in their babies’ first 90 days of life, 69% at 6 months.
Medical Mythbusting Commentary for November 2, 2022 Source:Strong RSV vaccine data lifts hopes after years of futility
-
BioNTech founders say their company is working on adapting mRNA technology to produce cancer-fighting vaccines. They hope to have something by 2030.
Medical Mythbusting Commentary for October 18, 2022 Source:Vaccines to treat cancer possible by 2030, say BioNTech founders
-
Bivalent vaccine choices in Canada
Medical Mythbusting Commentary for October 12, 2022
-
Bivalent COVID vaccine now available to all Ontarians over 18 years of age. Why do we have the bivalent BA.1 version whilst the US has the BA.4 and 5?
Medical Mythbusting Commentary for September 26, 2022 Source:Bivalent COVID-19 booster shot available to all adults in Ontario starting Monday